Publications
67
Citations
1,765
Est. group size
~1
Recurring co-author estimate
Active years
14
Publishing since 2013
Razieh Kebriaei's research focuses on developing and testing combination therapies to fight drug-resistant bacterial infections, especially those involving biofilms (protective bacterial communities) like MRSA (methicillin-resistant Staphylococcus aureus), Enterococcus, and Pseudomonas aeruginosa. Much of the work involves combining bacteriophages (viruses that infect bacteria) with antibiotics to enhance treatment effectiveness, using laboratory and simulated infection models such as ex vivo endocarditis (heart valve infection) systems. This research aims to address the growing clinical problem of multidrug-resistant bacterial infections that are difficult to treat with antibiotics alone.
Publication output rose from 2017 through a peak in 2020, then settled into a steady pace of roughly 5-9 papers per year through 2023-2024, suggesting consistent ongoing activity rather than clear growth or decline.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms
Microbiology Spectrum · 2024
- Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an <i>ex vivo</i> simulated endocardial pharmacokinetic/pharmacodynamic model
Antimicrobial Agents and Chemotherapy · 2024
- MtlD as a therapeutic target for intestinal and systemic bacterial infections
Journal of Bacteriology · 2024
- Current therapies and challenges for the treatment of <i>Staphylococcus aureus</i> biofilm‐related infections
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2023
- Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms
Microbiology Spectrum · 2023
- Phage-antibiotic combinations against multidrug-resistant <i>Pseudomonas aeruginosa</i> in <i>in vitro</i> static and dynamic biofilm models
Antimicrobial Agents and Chemotherapy · 2023
- Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation <i>Ex Vivo</i> Model
Microbiology Spectrum · 2023
- Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant <i>Pseudomonas aeruginosa</i> in <i>ex vivo</i> simulated endocardial vegetation models
Antimicrobial Agents and Chemotherapy · 2023
- Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Biofilm Model
Antimicrobial Agents and Chemotherapy · 2023
- Clinical Appraisal of Cefiderocol in the Treatment of Non-fermenting Gram-Negative Bacilli
Current Infectious Disease Reports · 2023
- Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin
Infectious Diseases and Therapy · 2023
- Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: <i>In vitro</i> synergy testing
Journal of Applied Microbiology · 2022
- Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections <i>In Vitro</i> : Bacteriophage-Antibiotic Combination
Microbiology Spectrum · 2022
- Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility
Antibiotics · 2022
- Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium
Antibiotics · 2022
- Antimicrobial Agents and Chemotherapy×15
- Open Forum Infectious Diseases×15
- Antibiotics×9
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy×5
- Microbiology Spectrum×5
- Tammy Bannerman
Medicine · The Ohio State University
- Joshua S. Davis
Medicine · The Ohio State University
- Joany Van Balen
Medicine · The Ohio State University
- Kenneth I. Onyedibe
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Ching Yang
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile